SCHEMBL19923536

SCHEMBL19923536

CC[Si](CC)(CC)N1C(=O)N(c2ccccc2)C(=O)C1(C)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 7/20 0.49
PGR P06401 1/20 0.37
HTR1A P08908 1/20 0.37
HTR6 P50406 1/20 0.37
ADRA2A P08913 1/20 0.36
NISCH Q9Y2I1 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 3/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
BACE1 P56817 1/20 0.35
BACE2 Q9Y5Z0 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.35
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923532 0.85 ELANE (0.49) ELANEPGRHTR1AHTR6ADRA2A
SCHEMBL19923766 0.85 ELANE (0.44) ELANEPGRHTR1AHTR6GAA
SCHEMBL19923595 0.83 ELANE (0.50) ELANEADRA2ANISCHMEN1KMT2A
SCHEMBL19923558 0.82 ELANE (0.41) ELANEPGRHTR1AHTR6GAA
SCHEMBL19923573 0.82 HTR1A (0.43) HTR1AHTR6GAAALDH1A1BACE1
SCHEMBL19923705 0.82 ALDH1A1 (0.37) ELANEHTR1AHTR6GAAALDH1A1
SCHEMBL19923599 0.81 ELANE (0.41) ELANEPGRHTR1AHTR6ADRA2A
SCHEMBL19923654 0.76 ELANE (0.47) ELANEPGRHTR1AHTR6GAA
SCHEMBL19923574 0.75 ELANE (0.37) ELANEHTR1AHTR6GAAALDH1A1
SCHEMBL17716274 0.74 ELANE (0.52) ELANEPGRGAAALDH1A1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN ELANE 1249/4885PGR 3190/4885HTR1A 456/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM ELANE 1276/4885PGR 3551/4885HTR1A 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.